...
首页> 外文期刊>Gene: An International Journal Focusing on Gene Cloning and Gene Structure and Function >MiR-564 is down-regulated in osteosarcoma and inhibits the proliferation of osteosarcoma cells via targeting Akt
【24h】

MiR-564 is down-regulated in osteosarcoma and inhibits the proliferation of osteosarcoma cells via targeting Akt

机译:miR-564在骨肉瘤中抑制下调,并通过靶向akt抑制骨肉瘤细胞的增殖

获取原文
获取原文并翻译 | 示例

摘要

Aberrant expression of miRNAs has been observed in a variety of human cancers. In this study, we reported that miR-564 was down-regulated in human osteosarcoma (OS) cell lines and patients. Overexpression of miR-564 in OS cells suppressed the cell proliferation and induced cell apoptosis. Mechanistically, we identified Akt as a direct target of miR-564. Highly expressed miR-564 decreased the expression of Akt at both mRNA and protein level and consequently, inhibited the essential role of Akt in the glycolysis of OS cells. Notably, restoring the expression of Akt in miR-564 overexpressing cells recovered the glucose metabolism and cell growth. These results suggested that miR-564 inhibited the glycolysis and cell proliferation through directly targeting Akt, which highlighted the potential application of miR-564-Akt axis in the treatment of osteosarcoma.
机译:在各种人类癌症中观察到miRNA的异常表达。 在这项研究中,我们报告称MiR-564在人骨瘤(OS)细胞系和患者中受到了下调。 MIR-564在OS细胞中的过度表达抑制了细胞增殖和诱导细胞凋亡。 机械地,我们将AKT确定为MIR-564的直接目标。 高表达的miR-564降低了AKT在mRNA和蛋白质水平的表达,因此,抑制AKT在OS细胞糖醇分解中的基本作用。 值得注意的是,恢复MiR-564过表达细胞中Akt的表达回收了葡萄糖代谢和细胞生长。 这些结果表明MIR-564通过直接靶向AKT抑制糖酵解和细胞增殖,这突出显示MIR-564-AKT轴在骨肉瘤的治疗中的潜在应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号